skip navigation
| | Text Size: -A | A | A+

Picture of a male patient sitting in a chair hooked up to an IV. A female nurse is giving him Monoclonal Therapy. Monoclonal Antibody Therapy, Rogen-COV. Rogen-COV helps to quick start the immune system to build up antibodies to fight COVID -19.

CPMC Continues Monoclonal Antibody Therapy Program

Cabinet Peaks Medical Center continues to offer the latest Monoclonal Antibody Therapy, Regen-COV. Regen-COV helps to quick start the immune system to build up antibodies to fight COVID -19. Monoclonal Antibody Therapy has been available at CPMC since January 2021, and this latest weapon in our arsenal is designed to help patients combat the current Delta variant of COVID-19.

Monoclonal Antibody Therapy is approved for people who have recently been diagnosed with COVID-19 who meet very specific medical criteria. Additionally, it was recently approved for use in people for post-exposure "prophylaxis" (i.e. preventively) for those who meet certain criteria. In either case, Regen-COV monoclonal antibody therapy is administered through a one-hour intravenous (IV) infusion which is followed by a required one-hour observation period during which time the patient must remain with the infusion nurse at Cabinet Peaks Medical Center.

This therapeutic service is a one-time treatment for patients. It has been known to lead to a better patient outcome and to help avoid hospitalization and severe illness for people with COVID-19.

For more questions about Monoclonal Antibody Therapy, or to find out if you qualify for this treatment, please reach out to your primary care provider.